Filing Details

Accession Number:
0001140361-17-024400
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-07 18:18:45
Reporting Period:
2017-06-05
Filing Date:
2017-06-07
Accepted Time:
2017-06-07 18:18:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1302573 Oncomed Pharmaceuticals Inc OMED () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1260573 A Perry Karsen C/O Oncomed Pharmaceuticals, Inc.
800 Chesapeake Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-05 10,000 $3.46 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades in prices ranging from $3.340937 to $3.50, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.